Jyh-Ming Jimmy Juang and Tzu-Pin Lu contributed equally to this work.
Supplementary Materials Supplementary methods

Diagnostic criteria
BrS was definitively diagnosed when a coved-type ST-segment elevation (type I) pattern was observed in more than 1 right precordial lead (V1-V3) in the presence or absence of a sodium channel blocking agent (procainamide or flecainide) ( Figure S1 ), and in conjunction with at least 1 of the following criteria: SCD, documented ventricular fibrillation, polymorphic ventricular tachycardia, syncope, or nocturnal agonal respirations.
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Exon capture and multi-gene disease-targeted sequencing
To amplify the DNA of the 145 selected genes within the blood samples, exome capture was performed by using the NimbleGen 2.1 M HD array (Roche NimbleGen, Inc.; Madison, WI, USA). Briefly, the DNA extracted from blood samples were first sheared into approximately 200-bp fragments by sonication. Probe sequences in the exon capture array were designed based on the exon sequences of the 145 selected genes in the published human genome, version 19. The total length of the targeted region was 932,308 bp, and the products of exon-enriched DNA libraries were preserved for further library construction for NGS.
After amplifying the DNA samples, NGS was performed to obtain pair-end reads with 90 bp by using the Illumina Hiseq 2000 machine following the standard protocols provided by Illumina (San Diego, CA). Briefly, the exon-enriched DNA libraries were used to construct second libraries, and the DNA samples were sheared and ligated by using two unique adapters. Next, the ligated fragments in the 150-200-bp range were isolated by gel extraction and amplified using polymerase chain reaction (PCR). Libraries were constructed following the manufacturer protocols (Illumina, San Diego, CA). Emulsion PCR was performed to generate multiple colonies, and the products were bound to the surface of the flow cell through unique oligonucleotide sequence pairing with the adapter sequences. Nucleotide determination was carried out by extension and imaging, and lastly, the nucleotide sequences of DNA samples were generated from the images using specific software provided by the manufacturer.
Validation by mass spectrometry
In the Sequenom system, the targeting loci were genotyped according to the iPLEX protocol using the MassARRAY system. The SeqTool Document v1.0 (Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan) was used to design the primers for PCR, and the genotyping results were determined by using the MassARRAY TyperAnalyzer v3.3 software provided by Sequenom. Alternatively, the primers for VeraCode were designed by using the Illumina Assay Design Tool and the GoldenGate VeraCode oligo pool assay was performed using the Illumina BeadXpress reader. All experimental procedures were followed by an Illumina GoldenGate genotyping assay, and the genotyping results were scored and determined using Illumina GenomeStudio software version 1.0. Tables   Table S1 . Selected 12 BrS-associated genes (shown in red) and 133 genes involve all human sodium, potassium and calcium channels for exome sequencing. KCNC4  KCNH7  KCNJ6  KCNMB1  KCNT2  SCNN1A  CACNA1H  GPD1L  KCND1  KCNH8  KCNJ8  KCNMB2  KCNU1  SCNN1B  CACNA1I  HCN4  KCND2  KCNIP1  KCNJ9  KCNMB3  KCNV1  SCNN1D  CACNA1S  KCNA1  KCND3  KCNIP2  KCNK1   KCNMB3P1 KCNV2 SCNN1G   CACNA2D1 KCNA10  KCNE1  KCNIP3  KCNK10  KCNMB4  MOG1  SLC4A4  CACNA2D2  KCNA2  KCNE2  KCNIP4  KCNK12  KCNN1  NALCN  SLC4A5  CACNA2D3  KCNA3  KCNE3  KCNJ1  KCNK13  KCNN2  SCN1A  CACNA2D4  KCNA4  KCNE4  KCNJ10  KCNK15  KCNN3  SCN1B  CACNB1  KCNA5  KCNF1  KCNJ11  KCNK16  KCNN4  SCN2A  CACNB2  KCNA6  KCNG1   KCNJ12 KCNK17   KCNQ1  SCN2B  CACNB3  KCNA7  KCNG2  KCNJ13  KCNK18  KCNQ2  SCN3A  CACNB4  KCNAB1  KCNG3  KCNJ14  KCNK2  KCNQ3  SCN3B  CACNG1  KCNAB2  KCNG4  KCNJ15  KCNK3 KCNQ4 SCN4A 
Supplementary
CACNA1A CACNG2 KCNAB3 KCNH1 KCNJ16 KCNK4 KCNQ5 SCN4B CACNA1B CACNG3 KCNB1 KCNH2 KCNJ18 KCNK5 KCNRG SCN5A CACNA1C CACNG4 KCNB2 KCNH3 KCNJ2 KCNK6 KCNS1 SCN7A CACNA1D CACNG5 KCNC1 KCNH4 KCNJ3 KCNK7 KCNS2 SCN8A CACNA1E CACNG6 KCNC2 KCNH5 KCNJ4 KCNK9 KCNS3 SCN9A CACNA1F CACNG7 KCNC3 KCNH6 KCNJ5 KCNMA1 KCNT1 SCN10A CACNA1G CACNG8
